InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Nassif David W., Chief Financial Officer. Director active across 1 company, notably Sio Gene Therapies Inc.. Aggregated, 1 disclosures have been recorded. History available since 8 December 2021. The latest transaction was filed on 8 December 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Nassif David W. is the Chief Financial Officer at Sio Gene Therapies Inc. He is responsible for the company's financial management, overseeing financial planning and analysis. David plays a key role in financial strategy and regulatory compliance, contributing to the company's growth.